These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2856350)

  • 21. The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice.
    Bayer WL; Tegtmeier GE; Barbara JA
    Clin Haematol; 1984 Feb; 13(1):253-69. PubMed ID: 6327132
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusional transmitted viruses in pregnancy.
    Eleftheriou A; Kalakoutis G; Pavlides N
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():901-14. PubMed ID: 10091164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How safe is our blood?
    Gunson H
    Practitioner; 1989 Oct; 233(1476):1265. PubMed ID: 2559409
    [No Abstract]   [Full Text] [Related]  

  • 25. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Laboratory diagnosis of viral infections. 9. Viral infections related to blood transfusion and organ transplantation].
    Miyamoto A; Tsutsumi Y; Sato H; Maeda Y
    Rinsho Byori; 1998 Nov; Suppl 108():111-5. PubMed ID: 9921239
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.
    Kleinman SH; Lelie N; Busch MP
    Transfusion; 2009 Nov; 49(11):2454-89. PubMed ID: 19682345
    [No Abstract]   [Full Text] [Related]  

  • 30. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
    N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience.
    Sultan F; Mehmood T; Mahmood MT
    Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G; Seed CR; Wang F; Nie D; Farrugia A
    Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients, needles, and health care workers.
    Hibberd PL
    J Intraven Nurs; 1995; 18(2):65-76. PubMed ID: 7707172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The risk of substitution therapy with blood and blood products].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic transfusion hepatitis--an underestimated disease].
    Henschel M; Kilburg M; Feurle GE
    Med Klin (Munich); 1996 Jul; 91(7):438-41. PubMed ID: 8756110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Post-transfusion hepatitis: the point of view of the infectious disease specialist].
    Giusti G; Galanti B
    Ric Clin Lab; 1984; 14 Suppl 1():3-16. PubMed ID: 6429829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.